{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:53:49Z","timestamp":1776750829401,"version":"3.51.2"},"reference-count":35,"publisher":"American Diabetes Association","issue":"11","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,11,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>To determine incidence and prevalence of diabetes mellitus (DM) after lung transplantation (LTx), identify risk factors for persistent DM after LTx, and determine its effect on survival.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>This was a prospective, longitudinal study comparing DM status before and after LTx using oral glucose tolerance tests (OGTTs). DM prevalence and changes in metabolic control over time were determined. Risk factors for persistent DM and survival differences by DM status were assessed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Between August 2010 and December 2012, 156 patients underwent LTx. DM prevalence after 3, 12, and 24 months was 47%, 44%, and 40%, respectively. A further 20%, 11%, and 7% had impaired glucose tolerance and\/or impaired fasting glucose. Incidence of new-onset DM after transplant (NODAT) was 32%, 30%, and 24% after 3, 12, and 24 months. Nonfasting insulin levels and second phase insulin release fell 3 months after transplant (Tx) but returned to baseline by 2 years. The only risk factors for NODAT were 1- and 2-h glucose levels on pre-Tx OGTT (OR 1.73 [95% CI 1.19\u20132.50], P = 0.004, and 1.84 [1.22\u20132.77], P = 0.004, respectively). Survival was reduced in patients with DM at study end versus those without (estimated mean 979 days [95% CI 888\u20131,071] vs. 1,140 days [1,070\u20131,210], P = 0.023).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Most patients had dysglycemia during the first year after LTx, and 32% developed NODAT. Hyperglycemia was caused both by \u03b2-cell dysfunction and by insulin resistance. Only pre-Tx OGTT glucose levels predicted persistent NODAT. As DM was common and associated with reduced survival, early detection and management of DM in LTx recipients are warranted.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc14-0663","type":"journal-article","created":{"date-parts":[[2014,9,6]],"date-time":"2014-09-06T07:24:46Z","timestamp":1409988286000},"page":"2919-2925","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":42,"title":["Prevalence and Predictors of Diabetes After Lung Transplantation: A Prospective, Longitudinal Study"],"prefix":"10.2337","volume":"37","author":[{"given":"Kathryn L.","family":"Hackman","sequence":"first","affiliation":[{"name":"Department of Medicine, Monash University, Melbourne, Australia"},{"name":"Department of Endocrinology and Diabetes, Alfred Hospital, Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory I.","family":"Snell","sequence":"additional","affiliation":[{"name":"Department of Medicine, Monash University, Melbourne, Australia"},{"name":"Lung Transplant Service, Alfred Hospital, Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon A.","family":"Bach","sequence":"additional","affiliation":[{"name":"Department of Medicine, Monash University, Melbourne, Australia"},{"name":"Department of Endocrinology and Diabetes, Alfred Hospital, Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2014,10,10]]},"reference":[{"key":"2022031220301760500_B1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1399-0012.2005.00359.x","article-title":"Guidelines for the treatment and management of new-onset diabetes after transplantation","volume":"19","author":"Wilkinson","year":"2005","journal-title":"Clin Transplant"},{"key":"2022031220301760500_B2","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.healun.2013.08.007","article-title":"The Registry of the International Society for Heart and Lung Transplantation: thirtieth adult lung and heart-lung transplant report\u20132013; focus theme: age","volume":"32","author":"Yusen","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"2022031220301760500_B3","doi-asserted-by":"crossref","first-page":"E237","DOI":"10.1111\/ctr.12098","article-title":"Early development of metabolic syndrome in patients subjected to lung transplantation","volume":"27","author":"Savioli","year":"2013","journal-title":"Clin Transplant"},{"key":"2022031220301760500_B4","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.healun.2005.01.004","article-title":"New-onset cardiovascular risk factors in lung transplant recipients","volume":"24","author":"Silverborn","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"2022031220301760500_B5","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1111\/j.1464-5491.2012.03676.x","article-title":"Diabetes before and after lung transplantation in patients with cystic fibrosis and other lung diseases","volume":"29","author":"Belle-van Meerkerk","year":"2012","journal-title":"Diabet Med"},{"key":"2022031220301760500_B6"},{"key":"2022031220301760500_B7","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1399-0012.2010.01383.x","article-title":"Risk factors for development of new-onset diabetes mellitus after transplant in adult lung transplant recipients","volume":"25","author":"Ye","year":"2011","journal-title":"Clin Transplant"},{"key":"2022031220301760500_B8","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/ajt.12561","article-title":"Diabetes is a major risk factor for mortality after lung transplantation","volume":"14","author":"Hackman","year":"2014","journal-title":"Am J Transplant"},{"key":"2022031220301760500_B9"},{"key":"2022031220301760500_B10","first-page":"131","article-title":"The Alfred Hospital lung transplant experience","author":"Snell","year":"2007","journal-title":"Clin Transpl"},{"key":"2022031220301760500_B11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1164\/ajrccm.160.1.9811017","article-title":"Maximizing the utilization of donor organs offered for lung transplantation","volume":"160","author":"Gabbay","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2022031220301760500_B12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.healun.2006.03.011","article-title":"International guidelines for the selection of lung transplant candidates: 2006 update\u2014a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation","volume":"25","author":"Orens","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"2022031220301760500_B13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1053-2498(00)00071-1","article-title":"Maximizing thoracic organ transplant opportunities: the importance of efficient coordination","volume":"19","author":"Snell","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"2022031220301760500_B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1540-8191.1994.tb00818.x","article-title":"Techniques and results in bilateral sequential single lung transplantation. The National Heart & Lung Replacement Service","volume":"9","author":"Esmore","year":"1994","journal-title":"J Card Surg"},{"key":"2022031220301760500_B15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"2022031220301760500_B16","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.2337\/diacare.26.8.2426","article-title":"Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients","volume":"26","author":"Yokoyama","year":"2003","journal-title":"Diabetes Care"},{"key":"2022031220301760500_B17","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"Katz","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031220301760500_B18","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2337\/diacare.24.4.796","article-title":"Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times","volume":"24","author":"Stumvoll","year":"2001","journal-title":"Diabetes Care"},{"key":"2022031220301760500_B19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.healun.2012.10.010","article-title":"An unexpectedly high prevalence of undiagnosed diabetes in patients awaiting lung transplantation","volume":"32","author":"Hackman","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"2022031220301760500_B20","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.2337\/dc12-2067","article-title":"Can new-onset diabetes after kidney transplant be prevented?","volume":"36","author":"Chakkera","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031220301760500_B21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1573399052952604","article-title":"New-onset posttransplantation diabetes mellitus: insulin resistance or insulinopenia? Impact of immunosuppressive drugs, cytomegalovirus and hepatitis C virus infection","volume":"1","author":"Hjelmesaeth","year":"2005","journal-title":"Curr Diabetes Rev"},{"key":"2022031220301760500_B22","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/ndt\/gfs583","article-title":"Novel views on new-onset diabetes after transplantation: development, prevention and treatment","volume":"28","author":"Hecking","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2022031220301760500_B23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1034\/j.1399-0012.2002.02059.x","article-title":"The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation","volume":"16","author":"Hjelmesaeth","year":"2002","journal-title":"Clin Transplant"},{"key":"2022031220301760500_B24","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1093\/ndt\/gfg338","article-title":"A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients","volume":"18","author":"Hagen","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"2022031220301760500_B25","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1681\/ASN.2007010109","article-title":"Glycemic control and critical illness: is the kidney involved?","volume":"18","author":"Mehta","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2022031220301760500_B26","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s001250051322","article-title":"Autonomic regulation of islet hormone secretion--implications for health and disease","volume":"43","author":"Ahr\u00e9n","year":"2000","journal-title":"Diabetologia"},{"key":"2022031220301760500_B27","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/ajt.12663","article-title":"A randomized, double-blind, placebo-controlled, multicenter study of rabbit ATG in the prophylaxis of acute rejection in lung transplantation","volume":"14","author":"Snell","year":"2014","journal-title":"Am J Transplant"},{"key":"2022031220301760500_B28","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.healun.2010.05.010","article-title":"Impact of previous cardiovascular disease on the outcome of lung transplantation","volume":"29","author":"Plantier","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"2022031220301760500_B29","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N Engl J Med"},{"key":"2022031220301760500_B30","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/aje\/kwi076","article-title":"Lung function and glucose metabolism: an analysis of data from the Third National Health and Nutrition Examination Survey","volume":"161","author":"McKeever","year":"2005","journal-title":"Am J Epidemiol"},{"key":"2022031220301760500_B31","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1464-5491.2010.03073.x","article-title":"Systematic review of the association between lung function and type 2 diabetes mellitus","volume":"27","author":"Klein","year":"2010","journal-title":"Diabet Med"},{"key":"2022031220301760500_B32"},{"key":"2022031220301760500_B33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/dc10-1604","article-title":"Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis","volume":"34","author":"Brodsky","year":"2011","journal-title":"Diabetes Care"},{"key":"2022031220301760500_B34","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.healun.2012.08.004","article-title":"The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012","volume":"31","author":"Christie","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"2022031220301760500_B35","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1681\/ASN.2011080835","article-title":"Early basal insulin therapy decreases new-onset diabetes after renal transplantation","volume":"23","author":"Hecking","year":"2012","journal-title":"J Am Soc Nephrol"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/37\/11\/2919\/620188\/2919.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/37\/11\/2919\/620188\/2919.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T22:30:41Z","timestamp":1647124241000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/37\/11\/2919\/29161\/Prevalence-and-Predictors-of-Diabetes-After-Lung"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,10]]},"references-count":35,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,10,10]]},"published-print":{"date-parts":[[2014,11,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc14-0663","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,10]]}}}